µ±Ç°ÔÚÏßÈËÊý11364
Ê×Ò³ - ·ÖÀàÌÖÂÛÇø - ѧÊõѧ¿Æ - ÖÆÒ©°æ - ͬÖ÷ÌâÔĶÁÎÄÕÂ

´ËƪÎÄÕ¹²ÊÕµ½´òÉÍ
0

  • 10
  • 20
  • 50
  • 100
ÄúĿǰα±ÒÓà¶î£º0
δÃû½»ÓÑ
[¸ü¶à]
[¸ü¶à]
molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
[°æÃæ:ÖÆÒ©][Êׯª×÷Õߣºabasin] , 2019Äê01ÔÂ03ÈÕ13:12:38 ,2291´ÎÔĶÁ,20´Î»Ø¸´
À´APP»Ø¸´£¬×¬È¡¸ü¶àα±Ò ¹Ø×¢±¾Õ¾¹«Öںţº
[·ÖÒ³:1 ]
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 1 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·Âð£¿
¹Ø¼ü×Ö: CADD,molecular modeling
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Thu Jan  3 13:12:38 2019, ÃÀ¶«)

±¾ÈËÔÚmolecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬PhD + Postdoc£¬ÊìϤÕâ¸öÁìÓò
µÄ¸÷ÖÖtricks(QM, MD, QM/MM, docking, QSAR,...)£¬Ïà¹ØÈí¼þÒÔ¼°Python±à³Ì£¬Ò²ÓÐ
һЩÎÄÕ·¢±í£¬½ÓÏÂÀ´Ïë×ªÖÆÒ©»¹ÓÐÏ·Âð£¿

Çë¸÷λǰ±²²»ÁߴͽÌ
--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 160.]

 
caozheng
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 2 ]

·¢ÐÅÈË: caozheng (zheng), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sat Jan 26 01:33:09 2019, ÃÀ¶«)

Ò©³§Ä£ÄâÕеͼÊÇpkÄ£Ä⣬ºÍϵͳģÄ⣬×îºóÃæÊÔÒªÓÐÒ»¸ö±È½ÏÍêÕûµÄstory, ÄãȱµÄ
¾ÍÊÇÒ»¸öproject, ÄÜ·¢Ò»ÆªÏà¹ØµÄÎÄÕ£¬¹ÒÃûµÄ¶¼ÐУ¬×îºóÄܰÑÕû¸öproject
presentation ×öºÃ¾ÍÐÐÁË¡£Èç¹û»¹ÄÜ×ö²©ºóÈ¥ÕÒ¸öÏà¹ØÊµÑéÊÒ×öÒ»Á½Ä격ºó¾ÍÐУ¬Òª
ÊÇÔÙ¼ÓһƪÎÄÕ£¬ÖÁÉÙÄÜÈÃÄãÓиöÃæÊÔ£¬offer¾ÍÒª¿´ÄãµÄ·¢»ÓºÍʵ¼ÊˮƽÁË
--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 2600:1700:e680:]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 3 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Mon Jan 28 12:03:39 2019, ÃÀ¶«)

ллָµã🙏£¡È·Êµ£¬ÎÒ·¢ÏÖÕÐpk/pdÒÔ¼°ADMETÔ¤²âµÄºÜ¶à¡£ÎÒÒÔºóµÃ¶à¿´¿´Õâ
·½ÃæµÄ¶«Î÷¡£Computational chemistry·½ÃæÎÒµ¹ÊÇÓÐһƬJCIMµÄÎÄÕ£¬ÊÇÓëÓлúºÏ³É
µÄͬѧһÆð×öµÄ£¬ÎÒ×ö¼ÆËãËûÃÇ×öºÏ³É²âÊÔ£¬Ð§¹û»¹²»´í£¬·¢ÏÖһЩ5-HT1AÊÜÌåÏà¹ØµÄ
¸ßÑ¡ÔñÐԸ߻îÐÔ¼¤¶¯¼Á¡£²»ÖªµÀÒ©³§Õâ·½ÃæµÄλÖÃÓÐûÓС£


¡¾ ÔÚ caozheng (zheng) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: Ò©³§Ä£ÄâÕеͼÊÇpkÄ£Ä⣬ºÍϵͳģÄ⣬×îºóÃæÊÔÒªÓÐÒ»¸ö±È½ÏÍêÕûµÄstory, ÄãȱµÄ
: ¾ÍÊÇÒ»¸öproject, ÄÜ·¢Ò»ÆªÏà¹ØµÄÎÄÕ£¬¹ÒÃûµÄ¶¼ÐУ¬×îºóÄܰÑÕû¸öproject
: presentation ×öºÃ¾ÍÐÐÁË¡£Èç¹û»¹ÄÜ×ö²©ºóÈ¥ÕÒ¸öÏà¹ØÊµÑéÊÒ×öÒ»Á½Ä격ºó¾ÍÐУ¬Òª
: ÊÇÔÙ¼ÓһƪÎÄÕ£¬ÖÁÉÙÄÜÈÃÄãÓиöÃæÊÔ£¬offer¾ÍÒª¿´ÄãµÄ·¢»ÓºÍʵ¼ÊˮƽÁË



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 160.]

 
caozheng
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 4 ]

·¢ÐÅÈË: caozheng (zheng), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Wed Jan 30 01:39:04 2019, ÃÀ¶«)


¡¾ ÔÚ abasin (͵×ÅÀÖ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ллָµã🙏£¡È·Êµ£¬ÎÒ·¢ÏÖÕÐpk/pdÒÔ¼°ADMETÔ¤²âµÄºÜ¶à¡£ÎÒÒÔºóµÃ¶à¿´¿´Õâ
: ·½ÃæµÄ¶«Î÷¡£Computational chemistry·½ÃæÎÒµ¹ÊÇÓÐһƬJCIMµÄÎÄÕ£¬ÊÇÓëÓлúºÏ³É
: µÄͬѧһÆð×öµÄ£¬ÎÒ×ö¼ÆËãËûÃÇ×öºÏ³É²âÊÔ£¬Ð§¹û»¹²»´í£¬·¢ÏÖһЩ5-HT1AÊÜÌåÏà¹ØµÄ
: ¸ßÑ¡ÔñÐԸ߻îÐÔ¼¤¶¯¼Á¡£²»ÖªµÀÒ©³§Õâ·½ÃæµÄλÖÃÓÐûÓС£

»¹ÓоÍÊÇË¢ÌâתÂí¹¤ÁË£¬pythonĿǰ×îÁ÷ÐÐ

--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 2600:1700:e680:]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 5 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Wed Feb  6 14:25:24 2019, ÃÀ¶«)

лл£¡Ò²ÔÚ¿´data scienceÏà¹ØµÄ£¬ÎÒ×ö¹ýһЩmachine learning£¬Python±à³Ì»¹¿ÉÒÔ

¡¾ ÔÚ caozheng (zheng) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: »¹ÓоÍÊÇË¢ÌâתÂí¹¤ÁË£¬pythonĿǰ×îÁ÷ÐÐ



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 160.]

 
rainbowserie
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 6 ]

·¢ÐÅÈË: rainbowserie (²ÊºçϵÁÐ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Fri Feb  8 01:29:04 2019, ÃÀ¶«)

Óп¨Â𣿠Èç¹ûÓп¨µÄ»°¿ÉÒÔÏÈÕÒ¸öС¹«Ë¾¸É¸É£¬»ýÀÛµãÏà¹ØµÄ¾­ÑéÔÙÌø¡£

Õâ¸öÁìÓò»ù±¾ÊôÓÚÒѾ­ËÀµôµÄÁìÓò£¬ÊôÓÚ´ó¼Ò¶¼¼«Á¦»Ø±ÜµÄ·½Ïò¡£ÏÖÔÚ¸÷´ó¹«Ë¾Ð¡·Ö×Ó
Ò©researchÕâ¿éÍâ°üºÜÀ÷º¦£¬´ó·Ö×ÓÒ©research»ù±¾²»ÓÃMD simulation¡£Èç¹ûûÓÐÏà
¹ØµÄ¾­Ñ飬PKPDÕâ¿é¹À¼ÆÄãÒ²ºÜÄѼ·½øÈ¥¡£Õâ¿é´ó²¿·ÖÈ˶¼ÊÇҩѧԺµÄ²©Ê¿£¬ºÜ¶à²©Ê¿
ÆÚ¼ä¾ÍÓÐʵϰ¡£Ä㿴ןоõ¶«Î÷±È½ÏÏñ£¬Æäʵ²î±ð²»Ð¡¡£Ïë¼·½øÄǸöȦ×Ó£¬»¨µÄʱ¼ä»¹
²»ÈçË¢ÌâתÂëÄØ¡£

ÓÐÉí·ÝµÄ»°¿ÉÒÔÏÈ¿¿Ò»¸öС¹«Ë¾£¬È»ºóÒµÓàʱ¼ä¶àˢˢÌâ½øÒ»¸ötech¹«Ë¾£¬ÒÔºó·¢Õ¹Ç°
¾°¹ãÀ«µÄ¶à¡£

¡¾ ÔÚ abasin (͵×ÅÀÖ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ±¾ÈËÔÚmolecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬PhD + Postdoc£¬ÊìϤÕâ¸öÁìÓò
: µÄ¸÷ÖÖtricks(QM, MD, QM/MM, docking, QSAR,...)£¬Ïà¹ØÈí¼þÒÔ¼°Python±à³Ì£¬Ò²ÓÐ
: һЩÎÄÕ·¢±í£¬½ÓÏÂÀ´Ïë×ªÖÆÒ©»¹ÓÐÏ·Âð£¿
: Çë¸÷λǰ±²²»ÁߴͽÌ



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 76.]

 
ebblood
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 7 ]

·¢ÐÅÈË: ebblood (chris), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Fri Feb  8 13:06:58 2019, ÃÀ¶«)

½¨Òé¶¼×¼±¸×Å£¬¼ÓÇ¿×Ô¼º£¬

Ò²ºÍÂ¥Éϵľ­Ñé²î²»¶à£¬Ò©³§pkpd modeling ÊDz»´í£¬µ«Õâ¸öȦ×ÓÓиöÏÖÏó£¬Ã¤Ä¿ÃÔÐÅ
һЩѧУºÍ½ÌÊÚµÄѧÉú£¬°Ñ´ó¶àÊýÄÜÈ˶¼ÅųýÔÚÍ⣬ÎÞÂÛÄãÓжàÓÅÐã¡£¼«´óµÄÐÅÏ¢ºÍ»ú
»á²»¶Ô³Æ£¬»òÕß˵°×µã£¬ËûÃÇÒ²¸ù±¾²»ÐèҪʲôdata science »òÕßÅ£±Æcoding ¼¼ÄÜ£¬
¶¼ÊÇÀÏÌ×£¬±ê×¼µÄ¶«Î÷¡£ Äã×Ô¼º×öµÄ¶«Î÷Ò²ÐíÅ£±Æ£¬they do not buy that.
ÎÒµÄÈÏʶҲ²»Ò»¶¨¶Ô£¬Äã¿ÉÒÔ¶àÊÔÊÔ£¬Óöµ½open minded µÄÈËÒ²ÓпÉÄÜ£¬µ«¼«´ó¿ÉÄÜÊÇ
µÃµ½Ä³¸öѧУ×éÀïÈ¥×öÒ»¶Îʱ¼ä²Å»áÓлú»á/

Æäʵhealthcare, Ò©³§ÓкܶàÊý¾Ý·ÖÏíµÄ£¬±ÈÈçinfo system £¬operation data £¬rwd
¸ü¶àµÄÓõ½ÄãµÄ¼¼Êõ£¬»òÕßÖ±½ÓÈ¥×ö¹ãÒåµÄdata science£¬ÄǾͻú»á¶à¶àÁË£¬²»¹ý²»
ÖªµÀÄãÈ¥±ðµÄÐÐÒµ»á²»»á¾õµÃʧÂä¡£
--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 199.]

 
shizhuang
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 8 ]

·¢ÐÅÈË: shizhuang (), ÐÅÇø: Pharmaceutical
±ê  Ìâ: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Fri Feb  8 15:07:05 2019, ÃÀ¶«)

ÓÐÒâÏò»Ø¹úµ½¸ßУ·¢Õ¹Âð£¿

--
¡ù À´Ô´:¡¤ δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 172.]

 
BenZ1227
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 9 ]

·¢ÐÅÈË: BenZ1227 (), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Fri Feb  8 19:03:21 2019, ÃÀ¶«)

¸úÂ¥Ö÷±³¾°ÏàËÆ£¬ÎÒ²©Ê¿ÆÚ¼äÉõÖÁÊÇ´¿MD£¬ÕÒ¹¤×÷ÄѶȿ°±ÈµÇÌ죬ÓйýÈý¸ö»ú»á£¬Ò»¸ö
ÊÇGenentech£¬Ò»¸öÊÇIBM Watson£¬Á½¸öְλ¶¼ÊÇ×öMDµÄ£¬µÚÈý¸ö»ú»áÊÇŦԼµÄ
Schrodinger, Â¥Ö÷µÄ±³¾°£¬¸üÊʺÏŦԼµÄѦ¶¨ÚÌ£¬¿ÉÒÔÒ»ÊÔ¡£

³ý´ËÖ®Í⣬ҩ³§ÕеÄmodelingÈ«ÃÀÇüÖ¸¿ÉÊý£¬GenentechÓÐMDµÄ×飬µ«ÊÇ»ù±¾ÉÏÒ»¸öÂÜ
²·Ò»¸ö¿Ó£¬Ò»¹²Ò²¾ÍÈýËĸöÈË¡£Eli Lilyż¶û»áÅ׳öһЩ»ú»á¡£

×ÜÌåÀ´Ëµ£¬¹¤Òµ½ç³ýÁËѦ¶¨ÚÌÕâÖÖרÃÅ¿ª·¢Ä£ÄâÈí¼þµÄ¹«Ë¾£¬ÆäËûµÄ¹«Ë¾ÕÐÄ£Äâ×ܹ²Ò²
¾ÍÄÇô¼¸¸öְ룬¶øÕâô¼¸¸öְλÖУ¬¿ÉÄÜÅöµ½µÄ¾ºÕù¶ÔÊÖÓдóÅ£×éµÄ²©Ê¿²©ºó£¬ÏëÒª
³öÍ·£¬·Ç³£ÓÐÄѶȡ£


¡¾ ÔÚ abasin (͵×ÅÀÖ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ±¾ÈËÔÚmolecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬PhD + Postdoc£¬ÊìϤÕâ¸öÁìÓò
: µÄ¸÷ÖÖtricks(QM, MD, QM/MM, docking, QSAR,...)£¬Ïà¹ØÈí¼þÒÔ¼°Python±à³Ì£¬Ò²ÓÐ
: һЩÎÄÕ·¢±í£¬½ÓÏÂÀ´Ïë×ªÖÆÒ©»¹ÓÐÏ·Âð£¿
: Çë¸÷λǰ±²²»ÁߴͽÌ




--
¡î ·¢×Ô iPhone ÂòÂòÌá 1.24.09
--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 104.]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 10 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sat Feb  9 12:02:54 2019, ÃÀ¶«)

лл·ÖÏí£¡È·Êµ·¢ÏÖÓкܶàÓÐÒ©³§±³¾°µÄÈ˶¼²»ÏàÐÅÄ£Äâ»òÕßÐéÄâɸѡ³öÀ´µÄ½á¹û¡£Ä¿
ǰ»¹Ã»Óп¨¡£¡£¡£

¡¾ ÔÚ rainbowserie (²ÊºçϵÁÐ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: Óп¨Â𣿠Èç¹ûÓп¨µÄ»°¿ÉÒÔÏÈÕÒ¸öС¹«Ë¾¸É¸É£¬»ýÀÛµãÏà¹ØµÄ¾­ÑéÔÙÌø¡£
: Õâ¸öÁìÓò»ù±¾ÊôÓÚÒѾ­ËÀµôµÄÁìÓò£¬ÊôÓÚ´ó¼Ò¶¼¼«Á¦»Ø±ÜµÄ·½Ïò¡£ÏÖÔÚ¸÷´ó¹«Ë¾Ð¡·Ö×Ó
: Ò©researchÕâ¿éÍâ°üºÜÀ÷º¦£¬´ó·Ö×ÓÒ©research»ù±¾²»ÓÃMD simulation¡£Èç¹ûûÓÐÏà
: ¹ØµÄ¾­Ñ飬PKPDÕâ¿é¹À¼ÆÄãÒ²ºÜÄѼ·½øÈ¥¡£Õâ¿é´ó²¿·ÖÈ˶¼ÊÇҩѧԺµÄ²©Ê¿£¬ºÜ¶à²©Ê¿
: ÆÚ¼ä¾ÍÓÐʵϰ¡£Ä㿴ןоõ¶«Î÷±È½ÏÏñ£¬Æäʵ²î±ð²»Ð¡¡£Ïë¼·½øÄǸöȦ×Ó£¬»¨µÄʱ¼ä»¹
: ²»ÈçË¢ÌâתÂëÄØ¡£
: ÓÐÉí·ÝµÄ»°¿ÉÒÔÏÈ¿¿Ò»¸öС¹«Ë¾£¬È»ºóÒµÓàʱ¼ä¶àˢˢÌâ½øÒ»¸ötech¹«Ë¾£¬ÒÔºó·¢Õ¹Ç°
: ¾°¹ãÀ«µÄ¶à¡£



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 128.]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 11 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sat Feb  9 12:08:31 2019, ÃÀ¶«)

¿´ÁËÒ»ÏÂdata science£¬²»µ«Ö°Î»¶à¶øÇÒ¹¤×Ê»¹¸ßºÜ¶à¡£¡£¡£È·ÊµÏñÄã˵µÄ£¬Èç¹û³¹µ×
תÐÐÁËÒ²Óе㲻¸ÊÐİ¡£¬¾ÍÏñÊÖÀïÎÕ×ÅÍÀÁúµ¶£¬Ã»ÓÐÁú¿ÉÒÔÍÀ£¬Ö»ÄÜȥɱÖíÔ×Å£µÄ¸Ð¾õ


¡¾ ÔÚ ebblood (chris) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ½¨Òé¶¼×¼±¸×Å£¬¼ÓÇ¿×Ô¼º£¬
: Ò²ºÍÂ¥Éϵľ­Ñé²î²»¶à£¬Ò©³§pkpd modeling ÊDz»´í£¬µ«Õâ¸öȦ×ÓÓиöÏÖÏó£¬Ã¤Ä¿ÃÔÐÅ
: һЩѧУºÍ½ÌÊÚµÄѧÉú£¬°Ñ´ó¶àÊýÄÜÈ˶¼ÅųýÔÚÍ⣬ÎÞÂÛÄãÓжàÓÅÐã¡£¼«´óµÄÐÅÏ¢ºÍ»ú
: »á²»¶Ô³Æ£¬»òÕß˵°×µã£¬ËûÃÇÒ²¸ù±¾²»ÐèҪʲôdata science »òÕßÅ£±Æcoding ¼¼ÄÜ£¬
: ¶¼ÊÇÀÏÌ×£¬±ê×¼µÄ¶«Î÷¡£ Äã×Ô¼º×öµÄ¶«Î÷Ò²ÐíÅ£±Æ£¬they do not buy that.
: ÎÒµÄÈÏʶҲ²»Ò»¶¨¶Ô£¬Äã¿ÉÒÔ¶àÊÔÊÔ£¬Óöµ½open minded µÄÈËÒ²ÓпÉÄÜ£¬µ«¼«´ó¿ÉÄÜÊÇ
: µÃµ½Ä³¸öѧУ×éÀïÈ¥×öÒ»¶Îʱ¼ä²Å»áÓлú»á/
: Æäʵhealthcare, Ò©³§ÓкܶàÊý¾Ý·ÖÏíµÄ£¬±ÈÈçinfo system £¬operation data £¬
rwd
:  ¸ü¶àµÄÓõ½ÄãµÄ¼¼Êõ£¬»òÕßÖ±½ÓÈ¥×ö¹ãÒåµÄdata science£¬ÄǾͻú»á¶à¶àÁË£¬²»¹ý²»
: ÖªµÀÄãÈ¥±ðµÄÐÐÒµ»á²»»á¾õµÃʧÂä¡£



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 128.]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 12 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆ�
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sat Feb  9 12:10:06 2019, ÃÀ¶«)

ÍÞ̫СÁË£¬ÔÝʱûÓдòËã»Ø¹ú

¡¾ ÔÚ shizhuang () µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ÓÐÒâÏò»Ø¹úµ½¸ßУ·¢Õ¹Âð£¿



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 128.]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 13 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sat Feb  9 12:12:34 2019, ÃÀ¶«)

ȷʵÊÇÕâÑùµÄ£¬Schrodinger½üÆÚûÓкÏÊʵÄְλ¡£Ç°±²ºóÀ´×öʲôÁË£¿


¡¾ ÔÚ BenZ1227 () µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ¸úÂ¥Ö÷±³¾°ÏàËÆ£¬ÎÒ²©Ê¿ÆÚ¼äÉõÖÁÊÇ´¿MD£¬ÕÒ¹¤×÷ÄѶȿ°±ÈµÇÌ죬ÓйýÈý¸ö»ú»á£¬Ò»¸ö
: ÊÇGenentech£¬Ò»¸öÊÇIBM Watson£¬Á½¸öְλ¶¼ÊÇ×öMDµÄ£¬µÚÈý¸ö»ú»áÊÇŦԼµÄ
: Schrodinger, Â¥Ö÷µÄ±³¾°£¬¸üÊʺÏŦԼµÄѦ¶¨ÚÌ£¬¿ÉÒÔÒ»ÊÔ¡£
: ³ý´ËÖ®Í⣬ҩ³§ÕеÄmodelingÈ«ÃÀÇüÖ¸¿ÉÊý£¬GenentechÓÐMDµÄ×飬µ«ÊÇ»ù±¾ÉÏÒ»¸öÂÜ
: ²·Ò»¸ö¿Ó£¬Ò»¹²Ò²¾ÍÈýËĸöÈË¡£Eli Lilyż¶û»áÅ׳öһЩ»ú»á¡£
: ×ÜÌåÀ´Ëµ£¬¹¤Òµ½ç³ýÁËѦ¶¨ÚÌÕâÖÖרÃÅ¿ª·¢Ä£ÄâÈí¼þµÄ¹«Ë¾£¬ÆäËûµÄ¹«Ë¾ÕÐÄ£Äâ×ܹ²Ò²
: ¾ÍÄÇô¼¸¸öְ룬¶øÕâô¼¸¸öְλÖУ¬¿ÉÄÜÅöµ½µÄ¾ºÕù¶ÔÊÖÓдóÅ£×éµÄ²©Ê¿²©ºó£¬ÏëÒª
: ³öÍ·£¬·Ç³£ÓÐÄѶȡ£



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 128.]

 
rainbowserie
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 14 ]

·¢ÐÅÈË: rainbowserie (²ÊºçϵÁÐ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sat Feb  9 12:50:36 2019, ÃÀ¶«)

¿´µ½Õâ¸öÈ̲»×¡Ëµ¼¸¾ä£¬ÄãÌ«°Ñ×Ô¼ºµ±»ØÊÂÁË¡£ÄãÕâ¸öÍêÈ«¹»²»ÉÏÍÀÁúµ¶µÄË®×¼£¬ÖÁ¶à
Ò²¾ÍÊǽ­ºþÉÏÒѾ­ÌÔÌ­Á˵ĶþÈýÁ÷°ïÅÉÎ书¡£ÎÒ±¾¿Æ×ö¹ýÕâ¸ö£¬ÏÖÔÚ»ØÏëÆðÀ´£¬ÕâÍæÒâ
ÍêÈ«ÊÇÒ»¸öʱ´úµÄ²úÎÏëÏëÄã×Ô¼º»áʲô£¿Êýѧͳ¼Æ±ÈµÃÉÏͳ¼ÆPhDÂ𣿻úÆ÷ѧϰ±È
µÃÉÏcsרҵµÄ±¾¿ÆË¶Ê¿Â𣿾ÍËãÊÇÀíÂÛÎïÀíÍÆ¹«Ê½½¨Ä£ÐÍ£¬Äã±ÈµÃ¹ýÄÇЩÀíÂÛÎïÀí¿Æ°à
³öÉíµÄ²©Ê¿Âð£¿Ò©Ñ§Õâ¿é£¬ÕâЩɵ±ÆÂÛÎĵÄ×÷ÕßÓÐÄĸöÕæÕýÁ˽âÒ©Îï»úÀíÒÔ¼°Ò©Î↑·¢
µÄÁ÷³Ì£¿Óм¸¸öÕæÕýÈ¥×ö¹ýʵÑ飬»¹²»ÊÇÒ»ÅÄÄÔ´üÏë³öÀ´µÄ¡£¸÷ÖÖÄ£ÐÍתÀ´×ªÈ¥¾ÍÊÇÄÇ
Ð©ÆÆÍæÒ⣬¼¸¸ö´óÀл¹¸÷ÖÖ»¥ÏàÇÆ²»ÉÏ¡£¡£¡£

GenentechÀïÃæµÄÄǸö¸ãMDµÄ×éºÜ±ßÔµ»¯£¬µÀÀíºÜ¼òµ¥£¬´Ó½¨ÄǸö×鿪ʼʮÄêÁË£¬É¶Ò²
û×ö³öÀ´£¬¾ÍÊÇÁ¬Ò»¸öphase 2µÄÒ©¶¼Ã»ÓУ¬ÌåÖÆ½©»¯£¬ÖªÊ¶³Â¾É¡£ÄǶ«Î÷×î¶àÒ²¾Í¸ã
¸ãresearch·¢·¢ÎÄÕ°ÕÁË£¬¼´Ê¹ÊÇŵ½±ÊµÑéÊÒ³öÀ´µÄÕÕÑùºÜ¶àÈËÖ»ÄܻعúÆ­Ç®¡£

×îºó»¹ËµÒ»¾ä£¬±ðÒÔΪתdata science˵ת¾Íת¡£È¥Ò»ÏߵĹ«Ë¾bar·Ç³£µÄ¸ß¡£Äãû¿¨
µÄ»°»¹ÒªÃæÁÙÉí·Ýǩ֤µÄÎÊÌ⣬ÏëÏëÄãÐèÒªºÍcs£¬Í³¼Æ£¬Ô˳EEÒÔ¼°¾­¼Ãѧ¹¤¿ÆµÄ
PhD¾ºÕù£¬ÄãµÄÓÅÊÆÔÚÄĶù£¿

´¿´âÊÇ×÷ΪÁìÓòÍâµÄÈËËäȻ˵Á½¾ä¡£Ö®Ç°ÔÚij´óÒ©³§¹¤×÷½Ó´¥ÁËһЩÕâ¿éµÄÈË£¬Óижø
·¢¡£

¡¾ ÔÚ abasin (͵×ÅÀÖ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ¿´ÁËÒ»ÏÂdata science£¬²»µ«Ö°Î»¶à¶øÇÒ¹¤×Ê»¹¸ßºÜ¶à¡£¡£¡£È·ÊµÏñÄã˵µÄ£¬Èç¹û³¹µ×
: תÐÐÁËÒ²Óе㲻¸ÊÐİ¡£¬¾ÍÏñÊÖÀïÎÕ×ÅÍÀÁúµ¶£¬Ã»ÓÐÁú¿ÉÒÔÍÀ£¬Ö»ÄÜȥɱÖíÔ×Å£µÄ¸Ð¾õ
: rwd



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 76.]

 
UNER
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 15 ]

·¢ÐÅÈË: UNER (UNER), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sun Feb 10 11:41:17 2019, ÃÀ¶«)

Â¥ÉÏÕý½â£¬ÆäʵÍÀÁúµ¶µÄ¶¨ÒåÊÇÄãÕæÕýÓÃËüÍÀ¹ýÁú¡£ÞÑÐÄ×ÔÎÊ£¬CADDÕâô¶àÄ꣬ÄĸöÈË
ÓÃËü¿ª·¢¹ýÃæÊÀµÄÒ©Î´ÓÕâ¸öÒâÒåÉÏ˵£¬ÊµÓÃÐԺ͹±Ï×Á¬ pk/pd ¶¼²»Èç¡£

»¹ÊÇÄǾ仰£¬
·ÅÏÂÍÀµ¶£¬Á¢µØ³É·ð¡£
--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 81.]

 
abasin
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 16 ]

·¢ÐÅÈË: abasin (͵×ÅÀÖ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Mon Feb 11 11:36:16 2019, ÃÀ¶«)

¹þ¹þ¹þ ´óÏÀ˵µÄºÜ¶Ô¡£ÎÒÕâÒ²ÊÇ×Ô³°Ò»Ï£¬ÍÀÁúµ¶µÄÁúÐèÒª¼ÓÒýºÅ¡£¾ÍÏñÏÖʵÖÐûÓÐ
Áú£¬Ò²²¢Ã»ÓпÉÒÔÕæÕýÓÃÀ´É±ÁúµÄµ¶Ò»Ñù£¬Ä¿Ç°Õâ¸öCADDÊǸö»ð¿Óרҵ£¬·¢ÎÄÕ»¹¿ÉÒÔ
£¬ÔÚÏÖʵÖÐÓ¦Óò»´ó¡£Ñ§ÁËÕâô¶àÄêÕÒ¹¤×÷µÄʱºò·¢ÏÖûʲôÓô¦¡£¡£¡£¾ÍÏñºÃ²»ÈÝÄÃ
µ½ÁËÒ»°ÑËùνµÄ¿ÉÒÔɱÁúµÄµ¶£¬·¢ÏÖÏÖʵÖв¢Ã»ÓÐÁú¿ÉÒÔɱµÄ¸Ð¾õÒ»Ñù¡£

Äã˵µÄÒ²ÓÐµãÆ«¼¤£¬Ö÷ÒªÕë¶ÔMD¡£ÆäʵCADDÏÂÃæ»¹Óкܶ࣬±ÈÈçQM£¬molecular
docking, virtual screening, QSASµÈ¡£ÕâЩ¼¼ÊõÔÚÏÖʵӦÓÃÖи÷×ÔÓи÷×ÔµÄÎÊÌ⣬ÓÐ
µÄÊÜÖÆÓÚËã·¨¡¢ÓеÄÊÜÖÆÓÚÓ²¼þ£¬Í¬Ê±Ò²Óи÷×Եij¤´¦¡£ÆäʵÓõĺõϰ»¹ÊÇÄܹ»Ëõ¼ò
drug discoveryµÄ³É±¾µÄ¡£Õâ¸öÁìÓò×öµÄ±È½ÏºÃµÄ¹«Ë¾ÊÇÕâ¸ö³õ´´¹«Ë¾ https://www.
nimbustx.com/pipeline/ ÓÐÒ»¸öÏîÄ¿ÒѾ­Âô¸øGILEADÁË£¬ÂôÁË$400m£¬ Èç¹ûÍêÈ«²»¿¿
Æ×µÄ»°£¬¿ÖÅÂûÓÐÈËÔ¸Ò⻨Õâô¶àÇ®Âò¡£

ʱ¼äºÍÊÂÎïÊÇ·¢Õ¹µÄ£¬¸Ð¾õÕâ¸öרҵÒÔºóÓ¦¸Ã»¹ÊÇ¿ÉÒԵ썹À¼Æµ½ÎÒÍËÐÝÖ®ºóÁË ¹þ¹þ
£©£¬ÒòΪÕâÖÖ½¨Ä£µÄ·½·¨ÊÇÓÐÎïÀíѧºÍͳ¼ÆÈÈÁ¦Ñ§»ù´¡µÄ£¬ËüµÄÿ¸öfeatureÊÇ¿ÉÒÔ½â
Ê͵쬲»ÊÇblack box¡£Ëæ×żÆËã»úµÄ·¢Õ¹£¬ÕâЩ·½·¨·¢Õ¹Ò²ºÜ¿ì£¬¾ÍÏñMD£¬10Äêǰ£¬
Ö»ÄÜÄ£Ä⼸Íò¸öÔ­×Ó£¬¼¸Ê®ÄÉÃ룬ÏÖÔÚ¿ÉÒÔÄ£Ä⼸ʮÍò¸öÔ­×Ó£¬¼¸¸öºÁÃ룬µ±È»Õâ¸úÏÖ
ʵ»¹²îºÜÔ¶¡£ÔÙ¹ý¼¸¸ö10Ä꣬ÄÜÄ£Äâµ½¼¸Ê®·ÖÖÓ¼¸¸öСʱ¾ÍÓÐÒâÒåÁË¡£Ä¿Ç°£¬ËüµÄ³¤´¦
ÊÇ×ösamplingËã×ÔÓÉÄÜ£¬ÄÃËüȥɸѡҩÎï»òÕßÑо¿Ò©Îï´úл¿ÖÅÂÊDz»ÐУ¬ÄÇ·Ö±ðÊÇ
virtual screeningºÍQM/QSARËùÉó¤µÄ¡£¡£¡£

°¦£¬²»ËµÁË£¬ÏÖÔÚµÄÎÊÌâÊÇÕõÇ®Ñø¼Ò£¬ÒÔºóÎÒÍËÐÝÁË»òÕßÓÐÇ®ÁË£¬ÎÒ»¹ÊǻῪ¹«Ë¾×öÕâ
Ò»¿éµÄ ¹þ¹þ¹þ



¡¾ ÔÚ rainbowserie (²ÊºçϵÁÐ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ¿´µ½Õâ¸öÈ̲»×¡Ëµ¼¸¾ä£¬ÄãÌ«°Ñ×Ô¼ºµ±»ØÊÂÁË¡£ÄãÕâ¸öÍêÈ«¹»²»ÉÏÍÀÁúµ¶µÄË®×¼£¬ÖÁ¶à
: Ò²¾ÍÊǽ­ºþÉÏÒѾ­ÌÔÌ­Á˵ĶþÈýÁ÷°ïÅÉÎ书¡£ÎÒ±¾¿Æ×ö¹ýÕâ¸ö£¬ÏÖÔÚ»ØÏëÆðÀ´£¬ÕâÍæÒâ
: ÍêÈ«ÊÇÒ»¸öʱ´úµÄ²úÎÏëÏëÄã×Ô¼º»áʲô£¿Êýѧͳ¼Æ±ÈµÃÉÏͳ¼ÆPhDÂ𣿻úÆ÷ѧϰ±È
: µÃÉÏcsרҵµÄ±¾¿ÆË¶Ê¿Â𣿾ÍËãÊÇÀíÂÛÎïÀíÍÆ¹«Ê½½¨Ä£ÐÍ£¬Äã±ÈµÃ¹ýÄÇЩÀíÂÛÎïÀí¿Æ°à
: ³öÉíµÄ²©Ê¿Âð£¿Ò©Ñ§Õâ¿é£¬ÕâЩɵ±ÆÂÛÎĵÄ×÷ÕßÓÐÄĸöÕæÕýÁ˽âÒ©Îï»úÀíÒÔ¼°Ò©Î↑·¢
: µÄÁ÷³Ì£¿Óм¸¸öÕæÕýÈ¥×ö¹ýʵÑ飬»¹²»ÊÇÒ»ÅÄÄÔ´üÏë³öÀ´µÄ¡£¸÷ÖÖÄ£ÐÍתÀ´×ªÈ¥¾ÍÊÇÄÇ
: Ð©ÆÆÍæÒ⣬¼¸¸ö´óÀл¹¸÷ÖÖ»¥ÏàÇÆ²»ÉÏ¡£¡£¡£
: GenentechÀïÃæµÄÄǸö¸ãMDµÄ×éºÜ±ßÔµ»¯£¬µÀÀíºÜ¼òµ¥£¬´Ó½¨ÄǸö×鿪ʼʮÄêÁË£¬É¶Ò²
: û×ö³öÀ´£¬¾ÍÊÇÁ¬Ò»¸öphase 2µÄÒ©¶¼Ã»ÓУ¬ÌåÖÆ½©»¯£¬ÖªÊ¶³Â¾É¡£ÄǶ«Î÷×î¶àÒ²¾Í¸ã
: ¸ãresearch·¢·¢ÎÄÕ°ÕÁË£¬¼´Ê¹ÊÇŵ½±ÊµÑéÊÒ³öÀ´µÄÕÕÑùºÜ¶àÈËÖ»ÄܻعúÆ­Ç®¡£
: ...................



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 160.]

 
zg14
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 17 ]

·¢ÐÅÈË: zg14 (zg14), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Mon Feb 11 12:23:47 2019, ÃÀ¶«)

ÔÞÂ¥Ö÷µÄ·¢Ìû Â¥ÉÏÌÖÂ۵ͼºÜÓмûµØ

Â¥ÉÏ´óÏÀºÍÆäËûÒµÄÚר¼ÒÔÚÏÂÃæÕâ¸öÌû×ÓÀïµÄÏà¹ØÌÖÂÛÒ²ºÜÓÐÆô·¢ÐÔ
http://mitbbs.com/article_t/JobHunting/33461661.html

ÆäʵºÜ¶àÈË´ôÔÚÕâ¸öÁìÓò ¿ÉÄܴ󲿷ÖÊÇÓнÄÐÒÐÄÀïºÍ»ú»áÖ÷Òå
Ò²ÐíÍòÒ»ÄÄÌìÄÜ¿ª´´¸öз½·¨ ¿ª¸ö¹«Ë¾È¦´óÇ® ´øÀ´¸öС¸ïÃü Ïñ´òÓ¡»úÒ»ÑùÍù³öÅçÒ©
¡£¡£

µ«Ï¸ÏëһϠ²»¶Ô ÎÒÃÇ×öµÄÕâЩ¶«Î÷ÒѾ­ÓбÈÎÒÃÇÅ£ºÜ¶àµÄÈË×öÁ˼¸Ê®Äê Ҳû×ö³öÀ´
ʲô¡£¡£³ýÁËAIºÍÓ²¼þ½ø²½ ÎÒÃÇÓÐʲôж«Î÷£¿

¶Ô¸öÈËÀ´Ëµ ÅöÉÏ»úÓöµÄ¸ÅÂÊÓжà´ó£¿¡£¡£


¡¾ ÔÚ abasin (͵×ÅÀÖ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ¹þ¹þ¹þ ´óÏÀ˵µÄºÜ¶Ô¡£ÎÒÕâÒ²ÊÇ×Ô³°Ò»Ï£¬ÍÀÁúµ¶µÄÁúÐèÒª¼ÓÒýºÅ¡£¾ÍÏñÏÖʵÖÐûÓÐ
: Áú£¬Ò²²¢Ã»ÓпÉÒÔÕæÕýÓÃÀ´É±ÁúµÄµ¶Ò»Ñù£¬Ä¿Ç°Õâ¸öCADDÊǸö»ð¿Óרҵ£¬·¢ÎÄÕ»¹¿ÉÒÔ
: £¬ÔÚÏÖʵÖÐÓ¦Óò»´ó¡£Ñ§ÁËÕâô¶àÄêÕÒ¹¤×÷µÄʱºò·¢ÏÖûʲôÓô¦¡£¡£¡£¾ÍÏñºÃ²»ÈÝÄÃ
: µ½ÁËÒ»°ÑËùνµÄ¿ÉÒÔɱÁúµÄµ¶£¬·¢ÏÖÏÖʵÖв¢Ã»ÓÐÁú¿ÉÒÔɱµÄ¸Ð¾õÒ»Ñù¡£
: Äã˵µÄÒ²ÓÐµãÆ«¼¤£¬Ö÷ÒªÕë¶ÔMD¡£ÆäʵCADDÏÂÃæ»¹Óкܶ࣬±ÈÈçQM£¬molecular
: docking, virtual screening, QSASµÈ¡£ÕâЩ¼¼ÊõÔÚÏÖʵӦÓÃÖи÷×ÔÓи÷×ÔµÄÎÊÌ⣬ÓÐ
: µÄÊÜÖÆÓÚËã·¨¡¢ÓеÄÊÜÖÆÓÚÓ²¼þ£¬Í¬Ê±Ò²Óи÷×Եij¤´¦¡£ÆäʵÓõĺõϰ»¹ÊÇÄܹ»Ëõ¼ò
: drug discoveryµÄ³É±¾µÄ¡£Õâ¸öÁìÓò×öµÄ±È½ÏºÃµÄ¹«Ë¾ÊÇÕâ¸ö³õ´´¹«Ë¾ https://www.
: nimbustx.com/pipeline/ ÓÐÒ»¸öÏîÄ¿ÒѾ­Âô¸øGILEADÁË£¬ÂôÁË$400m£¬ Èç¹ûÍêÈ«²»¿¿
: Æ×µÄ»°£¬¿ÖÅÂûÓÐÈËÔ¸Ò⻨Õâô¶àÇ®Âò¡£
: ...................


--

¡ù À´Ô´:¡¤BBS δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 72.]

 
rainbowserie
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 18 ]

·¢ÐÅÈË: rainbowserie (²ÊºçϵÁÐ), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Thu Feb 14 14:52:02 2019, ÃÀ¶«)

ÎÒ¾õµÃÄãÓ¦¸ÃÊDZ»Ï´ÄÔÁË£¬Õâ¸ö¶«Î÷absolutely²»¿ÉÄÜÓдó·¢Õ¹¡£ÒòΪÕâÐоø´ó²¿·ÖµÄ
½øÕ¹¶¼À´×ÔÓÚÆäËûÁìÓò£¬Äã¹À¼ÆÊDz»¶®¼ÆËã»úÓ²¼þ£¬Èí¼þµÄ£¬Ò²²»¶®ÈçºÎdesign²¢ÐÐËã
·¨£¬Èç¹ûÍæmachine learning model¡£ÆäʵÄãÊÇûÓÐʲôºËÐľºÕùÁ¦µÄ¡£

ÕâÐÐŵ½±µÄʵÑéÊÒ³öÀ´µÄÈË £¨Æäʵŵ½±±¾ÈËÖеÄÒ»¸öÎÒÒ²ÈÏʶ£©¡£Ã»¸Ð¾õÄÇЩÈ˳ö·
ºÃµ½ÄÄÀïÈ¥¡£ËµÊµ»°ÎÒҲû¸Ð¾õŵ½±±¾È˵ÄË®Æ½ÕæµÄºÜ¸ß¡£´µÅ£µÄÄÜÁ¦µ¹ÊÇÒ»¾ø¡£×÷Ϊ
ѧÊýѧͳ¼ÆµÄÈË£¬ÎÒ×î·´¸ÐÄǰïÒ»±²×ÓÖ»¶Ô×ÅÒ»¸öÄ£Ðͻ췹³ÔµÄÈË¡£µ±È»Åµ½±µÄ°ä·¢Õù
ÒéÒ²ºÜ´ó£¬±Ï¾¹ÒòΪÔÙÒ©³§¹¤×÷¹ýµÄ¹ØÏµÈÏʶ²»ÉÙŵ½±µÄ²©Ê¿²©ºó£¬ÓÐЩ»°¾Í²»Ïë¶à˵
ÁË¡£

ÆäʵÈç¹ûÄã²»ÊÇŵ½±»òÕßÐÐÒµÄÚtopʵÑéÊÒ³öÀ´µÄÈË£¬ÒÔºó¼´Ê¹ÕâÐÐÆðÀ´ÁË£¬ÄãÒ²ºÜÄÑ
·Öµ½Ò»±­¸þ¡£ ¶øÇÒÒ»¸ö¹«Ë¾Âô¸ö400m ¸ù±¾²»Ó¦¸ÃÓÐʲô¡£TechÐÐÒµ¶¯²»¶¯¾ÍÊÇ
billion dollarµÄÊÕ¹º£¬´ó¼ÒÐÄ̬²»Ò²Æ½ºÍµÄºÜ£º£©

¡¾ ÔÚ abasin (͵×ÅÀÖ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ¹þ¹þ¹þ ´óÏÀ˵µÄºÜ¶Ô¡£ÎÒÕâÒ²ÊÇ×Ô³°Ò»Ï£¬ÍÀÁúµ¶µÄÁúÐèÒª¼ÓÒýºÅ¡£¾ÍÏñÏÖʵÖÐûÓÐ
: Áú£¬Ò²²¢Ã»ÓпÉÒÔÕæÕýÓÃÀ´É±ÁúµÄµ¶Ò»Ñù£¬Ä¿Ç°Õâ¸öCADDÊǸö»ð¿Óרҵ£¬·¢ÎÄÕ»¹¿ÉÒÔ
: £¬ÔÚÏÖʵÖÐÓ¦Óò»´ó¡£Ñ§ÁËÕâô¶àÄêÕÒ¹¤×÷µÄʱºò·¢ÏÖûʲôÓô¦¡£¡£¡£¾ÍÏñºÃ²»ÈÝÄÃ
: µ½ÁËÒ»°ÑËùνµÄ¿ÉÒÔɱÁúµÄµ¶£¬·¢ÏÖÏÖʵÖв¢Ã»ÓÐÁú¿ÉÒÔɱµÄ¸Ð¾õÒ»Ñù¡£
: Äã˵µÄÒ²ÓÐµãÆ«¼¤£¬Ö÷ÒªÕë¶ÔMD¡£ÆäʵCADDÏÂÃæ»¹Óкܶ࣬±ÈÈçQM£¬molecular
: docking, virtual screening, QSASµÈ¡£ÕâЩ¼¼ÊõÔÚÏÖʵӦÓÃÖи÷×ÔÓи÷×ÔµÄÎÊÌ⣬ÓÐ
: µÄÊÜÖÆÓÚËã·¨¡¢ÓеÄÊÜÖÆÓÚÓ²¼þ£¬Í¬Ê±Ò²Óи÷×Եij¤´¦¡£ÆäʵÓõĺõϰ»¹ÊÇÄܹ»Ëõ¼ò
: drug discoveryµÄ³É±¾µÄ¡£Õâ¸öÁìÓò×öµÄ±È½ÏºÃµÄ¹«Ë¾ÊÇÕâ¸ö³õ´´¹«Ë¾ https://www.
: nimbustx.com/pipeline/ ÓÐÒ»¸öÏîÄ¿ÒѾ­Âô¸øGILEADÁË£¬ÂôÁË$400m£¬ Èç¹ûÍêÈ«²»¿¿
: Æ×µÄ»°£¬¿ÖÅÂûÓÐÈËÔ¸Ò⻨Õâô¶àÇ®Âò¡£
: ...................



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 144.]

 
femton
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 19 ]

·¢ÐÅÈË: femton (GO), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Tue Apr  2 17:30:18 2019, ÃÀ¶«)

Çë½Ì´óÅ££¬ÔڿɼûµÄ½«À´£¬ ±ÈÈçÊ®ÄêÄÚ£¬»á²»»áÓÐһЩ¸üеļÆËã»ú/ÐÅÏ¢¼¼Êõ´ó¹æÄ£
Ó¦ÓÃÔÚÒ©Î↑·¢ÁìÓò¡¢½Ï´ó¹æÄ£µØ¸Ä±äbiomedical industry? ´¿ºÃÆæ

¡¾ ÔÚ rainbowserie (²ÊºçϵÁÐ) µÄ´ó×÷ÖÐÌáµ½: ¡¿
: ÎÒ¾õµÃÄãÓ¦¸ÃÊDZ»Ï´ÄÔÁË£¬Õâ¸ö¶«Î÷absolutely²»¿ÉÄÜÓдó·¢Õ¹¡£ÒòΪÕâÐоø´ó²¿·ÖµÄ
: ½øÕ¹¶¼À´×ÔÓÚÆäËûÁìÓò£¬Äã¹À¼ÆÊDz»¶®¼ÆËã»úÓ²¼þ£¬Èí¼þµÄ£¬Ò²²»¶®ÈçºÎdesign²¢ÐÐËã
: ·¨£¬Èç¹ûÍæmachine learning model¡£ÆäʵÄãÊÇûÓÐʲôºËÐľºÕùÁ¦µÄ¡£
: ÕâÐÐŵ½±µÄʵÑéÊÒ³öÀ´µÄÈË £¨Æäʵŵ½±±¾ÈËÖеÄÒ»¸öÎÒÒ²ÈÏʶ£©¡£Ã»¸Ð¾õÄÇЩÈ˳ö·
: ºÃµ½ÄÄÀïÈ¥¡£ËµÊµ»°ÎÒҲû¸Ð¾õŵ½±±¾È˵ÄË®Æ½ÕæµÄºÜ¸ß¡£´µÅ£µÄÄÜÁ¦µ¹ÊÇÒ»¾ø¡£×÷Ϊ
: ѧÊýѧͳ¼ÆµÄÈË£¬ÎÒ×î·´¸ÐÄǰïÒ»±²×ÓÖ»¶Ô×ÅÒ»¸öÄ£Ðͻ췹³ÔµÄÈË¡£µ±È»Åµ½±µÄ°ä·¢Õù
: ÒéÒ²ºÜ´ó£¬±Ï¾¹ÒòΪÔÙÒ©³§¹¤×÷¹ýµÄ¹ØÏµÈÏʶ²»ÉÙŵ½±µÄ²©Ê¿²©ºó£¬ÓÐЩ»°¾Í²»Ïë¶à˵
: ÁË¡£
: ÆäʵÈç¹ûÄã²»ÊÇŵ½±»òÕßÐÐÒµÄÚtopʵÑéÊÒ³öÀ´µÄÈË£¬ÒÔºó¼´Ê¹ÕâÐÐÆðÀ´ÁË£¬ÄãÒ²ºÜÄÑ
: ·Öµ½Ò»±­¸þ¡£ ¶øÇÒÒ»¸ö¹«Ë¾Âô¸ö400m ¸ù±¾²»Ó¦¸ÃÓÐʲô¡£TechÐÐÒµ¶¯²»¶¯¾ÍÊÇ
: ...................



--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 8.]

 
Noahgen
½øÈëδÃûÐÎÏóÐã
ÎҵIJ©¿Í
[»Ø¸´] [»ØÐŸø×÷Õß] [±¾ÆªÈ«ÎÄ] [±¾ÌÖÂÛÇø] [ÐÞ¸Ä] [ɾ³ý] [ת¼Ä] [תÌù] [ÊÕ²Ø] [¾Ù±¨] [ 20 ]

·¢ÐÅÈË: Noahgen (), ÐÅÇø: Pharmaceutical
±ê  Ìâ: Re: molecular modeling (CADD)»ð¿Óרҵ»ì¼£¶àÄ꣬Ïë×ªÖÆÒ©»¹ÓÐÏ·
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Wed Apr  3 12:20:45 2019, ÃÀ¶«)

ÉúÎïÕâ¶«Î÷»¹µÃ¿¿ÊÔÑ飬´óͨÁ¿µÄɸѡ¡£ÏÖÔÚÓкܶà¸ßЧÂʵÄɸѡƽ̨£¬ CAADÊǺÍ
WETLAB ¾ºÕùµÄ¡£
¿¹ÌåµÄ½á¹¹Ñо¿ÒѾ­ºÜ¶àÁË£¬µ«ÊÇË­ÄÜÓÃCAADÉè¼Æ³öÒ»¸ö¿¹HIVµÄ¿¹Ì壿
--
¡ù À´Ô´:¡¤WWW δÃû¿Õ¼äÕ¾ ÍøÖ·£ºmitbbs.com ÒÆ¶¯£ºÔÚÓ¦ÓÃÉ̵êËÑË÷δÃû¿Õ¼ä¡¤[FROM: 2605:e000:141f:]

[·ÖÒ³:1 ]
[¿ìËÙ·µ»Ø] [ ½øÈëÖÆÒ©ÌÖÂÛÇø] [·µ»Ø¶¥²¿]
»Ø¸´ÎÄÕÂ
±êÌ⣺
ÄÚ ÈÝ£º

δÃû½»ÓÑ
½«ÄúµÄÁ´½Ó·ÅÔÚÕâ¶ù

ÓÑÇéÁ´½Ó


 

Site Map - Contact Us - Terms and Conditions - Privacy Policy

°æÈ¨ËùÓУ¬Î´Ãû¿Õ¼ä£¨mitbbs.com£©£¬since 1996